[Turner syndrome and genetic polymorphism: a systematic review]

about

Analysis of PTPN22, ZFAT and MYO9B polymorphisms in Turner Syndrome and risk of autoimmune disease.Sex chromosomes drive gene expression and regulatory dimorphisms in mouse embryonic stem cells.

P2860

Q38719855-26D3059B-7C74-42C9-BF82-B8C5D2AF2221 Q41451232-979E9CE4-339E-4A28-A26F-087B0967C788

P2860

[Turner syndrome and genetic polymorphism: a systematic review]

Item

http://www.wikidata.org/entity/Q36207657

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

[Turner syndrome and genetic polymorphism: a systematic review]

@ast

[Turner syndrome and genetic polymorphism: a systematic review]

@en

type

Item

label

[Turner syndrome and genetic polymorphism: a systematic review]

@ast

[Turner syndrome and genetic polymorphism: a systematic review]

@en

prefLabel

[Turner syndrome and genetic polymorphism: a systematic review]

@ast

[Turner syndrome and genetic polymorphism: a systematic review]

@en

P1476

[Turner syndrome and genetic polymorphism: a systematic review]

@en

P2093

Alessandra Bernadete Trovó de Marqui

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects

A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner's syndrome).

EFHC2 SNP rs7055196 is not associated with fear recognition in 45,X Turner syndrome.

C677T and A1298C polymorphisms of MTHFR gene and their relation to homocysteine levels in Turner syndrome

Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome.

A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome

Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.

Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome.

Y chromosome in Turner syndrome: review of the literature.

Growth hormone receptor polymorphism and growth hormone therapy response in children: a Bayesian meta-analysis.

P304

364-371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1016/J.RPPED.2014.11.014

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2015-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273465281

http://www.w3.org/2001/XMLSchema#string

P698

25765448

http://www.w3.org/2001/XMLSchema#string

P921

Turner syndrome

genetic variation

P932

4620965

http://www.w3.org/2001/XMLSchema#string

[Turner syndrome and genetic polymorphism: a systematic review]

about

P2860

P2860

[Turner syndrome and genetic polymorphism: a systematic review]

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P5875

P698

P921

P932